[L-Dopa treatment of parkinsonism].
D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*
D004295:Dihydroxyphenylalanine
L-Dopa-Behandlung des Parkinson-Syndroms.